RTIL 13 is a potent inhibitor of dynamin GTPase , with an IC 50 of 2.3 μM for dynamin I GTPase . RTIL 13 also targets pleckstrin homology lipid binding domain . RTIL 13 can inhibit receptor-mediated and synaptic vesicle endocytosis, with IC 50 s of 9.3 μM and 7.1 μM, respectively.

RTIL 13 inhibits receptor-mediated and synaptic vesicle endocytosis, with IC 50 s of 9.3 μM and 7.1 μM, respectively[2].

1009376-10-6

C30H55BrN2O3

571.67

RTIL 13

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years